• FOUNDED 2012

Overview

COSA members formed the cancer survivorship group in November 2012 in recognition of the growing importance of survivorship care of people diagnosed with cancer. Our multidisciplinary Group provides a platform for the discussion and ongoing development of survivorship care in Australia. We recognise that quality survivorship care is essential to supporting the well-being of people diagnosed with cancer and their families.

The overarching aim of the COSA Survivorship Group is to advance care and research to improve outcomes for all Australians after cancer treatment.

Group information

Survivorship Group objectives include:

  • Represent the needs of the broad range of health professionals involved in delivering care for cancer survivors
  • Provide a forum for education, discussion and exchange of information between health professionals involved in cancer survivorship care
  • Foster research in cancer survivorship
  • Promote and advocate for improved survivorship services and access to care for all Australians living with and beyond cancer
  • Engage stakeholders in the area of cancer survivorship care to ensure a coordinated, national approach to survivorship care in Australia and to facilitate policy development to inform such care

Working Groups

Advocacy

COSA Model of Care

The COSA Model of Survivorship Care is under review. Any members who want to contribute to the update should contact [email protected]

 

The 2025 National Cancer Survivorship Conference will be held in Melbourne from the 6-7 March 2025.

Collaborative Survivorship Webinars are available to all members 

Catch up on COSA Survivorship Group eNews from the last few years. The Survivorship Group eNews is only available for members, so you'll need to login to access.

COSA Survivorship Group on X (formally Twitter)
Follow and tag @COSA_Surviv
Community Guidelines 

Group Executive Committee
Chair: A/Prof Nicolas Hart, University of Technology Sydney, NSW 
Deputy Chair: Dr Kate Webber, Monash Health / Monash University, VIC
Prof Gail Garvey, The University of Queensland, QLD
Dr Mahesh Iddawela, Alfred Health & La Trobe Regional Hospital, VIC
Dr Carolyn Mazariego, University of New South Wales/SPHERE, NSW
Ms Rebecca McIntosh, healthAbility / Peter MacCallum Cancer Centre, VIC
Ms Carmel O’Kane, Wimmera Cancer Centre / Grampians Health Horsham, VIC
A/Professor Anna Ugalde, Deakin University VIC
Dr Thomas Walwyn, Perth Children's Hospital, WA

Co-opted Executive members
Chair, PRO Working Group: Prof Bogda Koczwara AM, Flinders Centre for Innovation in Cancer, SA 
eNews Co-editor: Dr Md Mijanur Rahman, The Daffodil Centre, NSW
eNews Co-editor: Dr Carla Thamm, Flinders University SA/Metro South Hospital and Health Service QLD 
Primary care advisor: Dr Sean Black-Tiong, Lift Cancer Care Services, SA
Dr Elysia Thornton-Benko, General Practice, University of New South Wales, NSW
Co-Chair, Financial Toxicity Working Group: Megan Varlow, Cancer Council Australia

Terms of Reference - Council approved 6 August 2021, updated May 2024

2022 - 2024 Survivorship Group Strategic Plan 

2023 Group AGM Minutes - 1 November

You can view all COSA Quickfires on our YouTube channel

What’s the latest

Group Chair

Group Chair Image
Group Chair

Nicolas Hart

Survivorship Group Chair